Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Locally Recurrent Nasopharyngeal Carcinoma
Phase I/II Trial Evaluating Carbon Ion Radiotherapy With Concurrent Chemotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma
Sponsor: Shanghai Proton and Heavy Ion Center
Terminated
Slow accrual of patients.
Other terminated trials from Shanghai Proton and Heavy Ion Center
- Hepatocellular Carcinoma · Phase NA · Oct 2023
- Nasopharyngeal Carcinoma · Phase PHASE1/PHASE2 · May 2017
See all terminations from Shanghai Proton and Heavy Ion Center
This PHASE1/PHASE2 trial investigates Nasopharyngeal Carcinoma and is currently terminated or withdrawn. Shanghai Proton and Heavy Ion Center leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1_PHASE2
-
Mar 2020 — Jan 2021 [monthly]
Terminated PHASE1_PHASE2
Status: Recruiting → Terminated
-
Jun 2018 — Mar 2020 [monthly]
Recruiting PHASE1_PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE1_PHASE2
First recorded
Sep 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Shanghai Proton and Heavy Ion Center
For direct contact, visit the study record on ClinicalTrials.gov .